These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17914488

  • 1. The immunohistochemical profile of the adenocarcinoma of upper gastric pole.
    Mărgăritescu C, Mogoantă L, Mănescu P, Simionescu C, Pirici D, Streba L, Mercuţ D.
    Rom J Morphol Embryol; 2007; 48(3):215-35. PubMed ID: 17914488
    [Abstract] [Full Text] [Related]

  • 2. A clinicopathological and immunohistochemical study of gastric cancer with squamous cell carcinoma components: a clinically aggressive tumor.
    Saito S, Hosoya Y, Morishima K, Ui T, Haruta H, Kurashina K, Meguro Y, Zuiki T, Sata N, Fujii H, Matsubara D, Niki T, Lefor AT, Yasuda Y.
    J Dig Dis; 2012 Aug; 13(8):407-13. PubMed ID: 22788926
    [Abstract] [Full Text] [Related]

  • 3. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
    Terada T.
    Int J Clin Exp Pathol; 2013 Aug; 6(4):630-8. PubMed ID: 23573309
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma.
    Niimi C, Goto H, Ohmiya N, Niwa Y, Hayakawa T, Nagasaka T, Nakashima N.
    Am J Clin Pathol; 2002 Nov; 118(5):683-92. PubMed ID: 12428787
    [Abstract] [Full Text] [Related]

  • 5. Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach.
    Xue L, Zhang X, Li Y, Yang H, Li X, Mi J, Wang H, Wang J, Yan X.
    Hum Pathol; 2011 Apr; 42(4):594-601. PubMed ID: 21146193
    [Abstract] [Full Text] [Related]

  • 6. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
    Mattioli S, Ruffato A, Di Simone MP, Corti B, D'Errico A, Lugaresi ML, Mattioli B, D'Ovidio F.
    Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical evaluation of the probability of skin metastasis in gastric cancer.
    Inadomi T, Tan M, Suzuki H, Shigematsu C.
    Eur J Dermatol; 1999 May; 9(3):214-7. PubMed ID: 10210788
    [Abstract] [Full Text] [Related]

  • 8. Hidradenocarcinoma: a histological and immunohistochemical study.
    Ko CJ, Cochran AJ, Eng W, Binder SW.
    J Cutan Pathol; 2006 Nov; 33(11):726-30. PubMed ID: 17083691
    [Abstract] [Full Text] [Related]

  • 9. Distribution of the carcinoembryonic antigen CEA in gastric lesions. Immunohistochemical testing of three novel monoclonal antibodies.
    Berner A, Børmer O, Marton PF, Nesland JM.
    Histol Histopathol; 1990 Apr; 5(2):199-204. PubMed ID: 2134373
    [Abstract] [Full Text] [Related]

  • 10. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
    Ishii HH, Gobe GC, Ebihara Y.
    Hepatogastroenterology; 2007 Apr; 54(79):2159-63. PubMed ID: 18251181
    [Abstract] [Full Text] [Related]

  • 11. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, Vassiliou V, Petsas T, Vagenas K, Zolota V, Scopa CD.
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
    Lazăr D, Tăban S, Raica M, Sporea I, Cornianu M, Goldiş A, Vernic C.
    Rom J Morphol Embryol; 2008 Feb; 49(2):137-48. PubMed ID: 18516318
    [Abstract] [Full Text] [Related]

  • 13. Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
    Han CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PH, Koo CL, Tyan YS.
    Arch Gynecol Obstet; 2010 Feb; 281(2):317-23. PubMed ID: 19444461
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
    Iijima M, Nakayama J, Nishizawa T, Ishida A, Ishii K, Ota H, Katsuyama T, Saida T.
    Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
    [Abstract] [Full Text] [Related]

  • 15. [Pathological study of hepatoid gastric adenocarcinomas].
    Song H, Li S, Yang Y.
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):56-9. PubMed ID: 7544725
    [Abstract] [Full Text] [Related]

  • 16. [Prognostic value of the cellular expression of carcinoembryonic antigen (CEA) in gastric adenocarcinoma].
    Monges G, Penault F, Seitz JF, Sandoval M, Delpero JR, Houvenaeghel G, Giovanini M, Gouvernet J, Hassoun J.
    Ann Pathol; 1991 Jan; 11(2):101-6. PubMed ID: 2053985
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes.
    Ohuchi N, Wunderlich D, Fujita J, Colcher D, Muraro R, Nose M, Schlom J.
    Cancer Res; 1987 Jul 01; 47(13):3565-71. PubMed ID: 3555774
    [Abstract] [Full Text] [Related]

  • 18. Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas.
    Tena-Suck ML, Salinas-Lara C, Arce-Arellano RI, Rembao-Bojórquez D, Morales-Espinosa D, Sotelo J, Arrieta O.
    Clin Neurol Neurosurg; 2006 Oct 01; 108(7):661-9. PubMed ID: 16500745
    [Abstract] [Full Text] [Related]

  • 19. [Clinicopathological analysis and differential diagnosis of primary peritoneal adenocarcinoma].
    Gong HL, Wang CB, Zhang GJ, Li CF, Yang XY, Hou HL, Zhang XB.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 24; 89(7):463-5. PubMed ID: 19567094
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis of the poorly differentiated stomach adenocarcinoma with medullary growth pattern.
    Umeda T, Sakamoto J, Watanabe T, Ito K, Akiyama S, Yasue M, Takagi H.
    J Surg Oncol; 1996 May 24; 62(1):34-9. PubMed ID: 8618398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.